The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Integrating data to improve CBCL diagnosis
Jean-Philippe Merlio
• 14 Oct 2021
Jean-Philippe Merlio, MD, PhD, Tumor Biology and Tumor Bank, CHU Bordeaux, Pessac, France, comments on his work proposing new ways of integrating data on cutaneous B-cell lymphoma (CBCL), in contrast to standard classifications, to improve the diagnosis of patients with CBCL. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
